Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer:A systematic review and meta-analysis

被引：0
|
作者：
Li, F. [1 ]
Lv, Z. [1 ]
Mao, Y. [1 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Thorac Surg, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100P
引用
收藏
页码：S1054 / S1054
页数：1
相关论文
共 50 条
  • [1] Association of clinical and molecular factors with immune checkpoint inhibitors efficacy in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, F.
    Lv, Z.
    Mao, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1574 - S1575
  • [2] Efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
    Yang, Fang
    Wang, Yucai
    Tang, Lin
    Mansfield, Aaron Scott
    Adjei, Alex A. A.
    Leventakos, Konstantinos
    Duma, Narjust
    Wei, Jia
    Wang, Lifeng
    Liu, Baorui
    Molina, Julian R. R.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Effect of histology on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer: A systematic review and meta-analysis
    Li, Feng
    Zhai, Suokai
    Lv, Zhuoheng
    Yuan, Ligong
    Wang, Shuaibo
    Jin, Donghui
    Yi, Hang
    Fu, Li
    Mao, Yousheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
    Yao, Jiacheng
    Li, Sihan
    Bai, Lu
    Chen, Jun
    Ren, Chengbo
    Liu, Tingting
    Qiu, Jingping
    Danga, Jun
    ECLINICALMEDICINE, 2025, 81
  • [5] Smoking history and the efficacy of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis
    Chen, Da-Li
    Li, Qing-Yuan
    Tan, Qun-You
    JOURNAL OF THORACIC DISEASE, 2021, 13 (01) : 220 - U123
  • [6] Safety and efficacy of retreatment with immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Cai, Zijing
    Zhan, Ping
    Song, Yong
    Liu, Hongbing
    Lv, Tangfeng
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1555 - 1566
  • [7] Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: A systematic review and meta-analysis
    Wang, Jiajun
    Cao, Liu
    Xu, Shun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [8] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Haizhu Chen
    Yu Feng
    Yu Zhou
    Yunxia Tao
    Le Tang
    Yuankai Shi
    Cancer Immunology, Immunotherapy, 2022, 71 : 3071 - 3085
  • [9] Immune checkpoint inhibitors in neoadjuvant therapy of non-small cell lung cancer: a systematic review and meta-analysis
    Ge, Sa
    Huang, Chenjun
    JOURNAL OF THORACIC DISEASE, 2022, 14 (02) : 333 - 342
  • [10] Brain metastases and immune checkpoint inhibitors in non-small cell lung cancer: a systematic review and meta-analysis
    Chen, Haizhu
    Feng, Yu
    Zhou, Yu
    Tao, Yunxia
    Tang, Le
    Shi, Yuankai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (12) : 3071 - 3085
12345